Market revenue in 2023 | USD 599.1 million |
Market revenue in 2030 | USD 931.0 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Otc rdt |
Fastest growing segment | OTC RDT |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC RDT, Professional RDT |
Key market players worldwide | ACON Laboratories, Abbott Laboratories, BD, BioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, Cardinal Health Inc, Creative Diagnostics, Roche, McKesson Corp, Meridian Bioscience, Trinity Biotech PLC ADR, Zoetis Inc Class A, Artron Bioresearch, Alfa Medical Group, BioNTech SE ADR, Sight Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rapid medical diagnostic kits market will help companies and investors design strategic landscapes.
Otc rdt was the largest segment with a revenue share of 62.91% in 2023. Horizon Databook has segmented the Italy rapid medical diagnostic kits market based on otc rdt, professional rdt covering the revenue growth of each sub-segment from 2018 to 2030.
According to Worldometer, as of June 10, 2020, there were around 235,763 confirmed cases of COVID19 in Italy, which has led to around 34,114 deaths. Several Italian regions have started mass COVID-19 testing using rapid antibody tests to control this pandemic.
Thus, SARS-CoV-2 pandemic in Italy has significantly increased the demand for rapid diagnostic tests in the country. Furthermore, rise in prevalence of hepatitis is anticipated to boost market growth during the forecast period. According to a report published by the European CDC, Italy showed the highest rate of hepatitis C virus infections in general population.
In addition, according to the International Diabetes Federation, there were an estimated 3,402,300 individuals diagnosed with diabetes in 2017. According to the same source, prevalence of diabetes in Italy was about 7.6% in 2017.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy rapid medical diagnostic kits market , including forecasts for subscribers. This country databook contains high-level insights into Italy rapid medical diagnostic kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account